首页|期刊导航|生命科学研究|程序性细胞坏死:从分子机制到疾病

程序性细胞坏死:从分子机制到疾病OA

Necroptosis:From Molecular Mechanisms to Diseases

中文摘要英文摘要

程序性细胞坏死(necroptosis)是一种由死亡受体启动、不依赖于胱天蛋白酶(cysteinyl aspartate specific proteinase,caspase)并由混合谱系激酶结构域样蛋白质(mixed lineage kinase domain-like protein,MLKL)介导的程序性细胞死亡方式,其在形态上表现出典型的坏死特征.该过程的核心信号通路始于死亡受体等信号的激活,关键步骤包括受体相互作用蛋白质激酶1(receptor-interacting protein kinase 1,RIPK1)与RIPK3形成复合体,进而招募并磷酸化下游关键效应蛋白质MLKL,最终导致质膜破裂.活化后的MLKL发生寡聚化并转位到质膜,通过直接成孔或间接调节离子通道的方式破坏膜完整性,引起细胞内物质外流和炎症反应.大量研究表明,程序性细胞坏死的调控异常与多种人类疾病的病理进程密切相关,包括炎症性疾病、免疫相关疾病、神经退行性疾病以及肿瘤等.本综述旨在系统总结程序性细胞坏死的分子机制、信号网络及其在相关疾病中的作用,以期为针对该通路的治疗策略提供理论支撑.

Necroptosis is a cysteinyl aspartate specific proteinase(caspase)-independent form of programmed cell death mediated by death receptors and executed by the mixed lineage kinase domain-like protein(MLKL),which exhibits typical morphological features of necrosis.The core signaling pathway of necroptosis is initiated by the activation of signals such as death receptors.Key steps include the complex formation of receptor-interacting protein kinase 1(RIPK1)and RIPK3,which subsequently recruits and phosphorylates the downstream effector MLKL,ultimately leading to plasma membrane rupture.Activated MLKL undergoes oligomerization and translocates to the plasma membrane,where it disrupts membrane integrity either by di-rect pore formation or indirect regulation of ion channels,resulting in intracellular content leakage and in-flammatory responses.Substantial evidence indicates that dysregulated necroptosis is closely associated with the pathophysiology of various human diseases,including inflammatory disorders,immune-related conditions,degenerative diseases,and cancer.This review aims to summarize the core molecular mechanisms and sig-naling networks of necroptosis,as well as its roles in related diseases,thereby providing a theoretical founda-tion for developing therapeutic strategies targeting this pathway.

宋新刚;宋国荣;段云蔚;蒲燕珍;陈浩杰;贺源;蔡振宇;郭瑜峰

上海电力医院烧伤整形外科,中国 上海 200050上海电力医院烧伤整形外科,中国 上海 200050上海电力医院烧伤整形外科,中国 上海 200050上海电力医院烧伤整形外科,中国 上海 200050上海电力医院烧伤整形外科,中国 上海 200050同济大学医学院,中国 上海 200092同济大学医学院,中国 上海 200092上海电力医院烧伤整形外科,中国 上海 200050

生物科学

程序性细胞坏死炎症人类疾病分子机制治疗策略

necroptosisinflammationhuman diseasemolecular mechanismtherapeutic strategy

《生命科学研究》 2026 (2)

95-108,14

国家自然科学基金面上项目(32170748)国网上海市电力公司科技项目(520900220007)

10.16605/j.cnki.1007-7847.2025.09.0182

评论